Effects of allicin on the proliferation,apoptosis,invasion and metastasis of cisplatin-resistant strains of endometrial carcinoma Ishikawa cells
WANG Jing,LI Xin,ZHOU Yun,HUANG Jinling,HONG Li
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2023.09.02
2023-01-01
Abstract:Objective To investigate the effect of allicin on the biological behavior of endometrial cancer cisplatin（DDP）-resistant cell line Ishikawa/DDP.Methods Cisplatin-resistant cell strains cultures of endometrial carcinoma were respectively constituted into control, cisplatin-treated,（low-dose allicin+cisplatin）-treated,（medium-dose allicin+cisplatin）-treated, and（high-dose allicin+cisplatin）-treated groups.The proliferation, invasion, metastasis and apoptosis of the cells in each group were detected by CCK8,transwell assay, scratch assay and flow cytometry, and the expression levels of MDR1 mRNA and P-gp protein in each group were detected by RT-qPCR and western blot assay, respectively.Results The inhibition rates of cell proliferation in the low-dose allicin+DDP-treated group,the medium-dose allicin+DDP-treated group and the high-dose allicin+DDP-treated group were（20.92±3.28）%,（31.71±2.82）% and（47.34±3.43）%,respectively,and the inhibition rates of cell proliferation increased with the increase of allicinconcentration,and the difference was significant（F=346.231,P=0.007）.Transwell experiments showed that the number of invading cells in the control,DDP-treated,low-dose allicin+DDP-treated,medium-dose allicin+DDP-treated and high-dose allicin+DDP-treated groups were（314.00±7.53）,（278.00±6.52）,（203.00±5.46）,（109.00±5.32）and（65.00±5.32）,respectively.The difference was statistically significant（F=437.807,P=0.009）.The scratch test showed that the relative proportions of scratch widths after 48hin the control,DDP-treated,low-dose allicin+DDP-treated,medium-dose allicin+DDP-treated and high-dose allicin+DDP-treated groups were（31.48±9.28）%,（33.76±7.43）%,（42.76±5.34）%,（53.56±7.45）% and（64.43±8.32）%,respectively,and the cell migration capacity decreased with increasing allicinconcentration,with statistically significant differences（F=345.126,P =0.005）.The flow cytometry results showed that the apoptosis rates in the control,DDP-treated,low-dose allicin+DDP-treated,medium-dose allicin+DDPtreated and high-dose allicin+DDP-treated groups were（11.32±1.13）%,（13.51±0.83）%,（21.30±1.56）%,（37.64±2.21）% and（51.31±2.42）%,the apoptosis rate increased significantly with increasing allicinconcentration and the difference was statistically significant（F=423.012,P=0.008）.RT-qPCR results showed that the relative expression of MDR1mRNA in the control,DDP-treated,low-dose allicin+DDP-treated,medium-dose allicin+DDP-treated and highdose allicin+DDP-treated groups were 48.16±0.53,42.38±1.52,30.45±0.46,21.34±0.32,12.36±0.41,respectively,and MDR1mRNA expression decreased with increasing allicinconcentration,with statistically significant differences（F=345.014,P=0.006）.Protein blotting experiments showed that the control,DDP-treated,and low dose allicin+DDP treated group,medium dose allicin+DDP treated group and high dose allicin+DDP treated group had P-gp protein expression levels of 0.86±0.04,0.67±0.03,0.49±0.05,0.27±0.04and 0.07±0.01,respectively,with the increase of allicinconcentration,the P-gp protein expression decreased and the difference was statistically significant（F=445.017,P=0.006）.Conclusion Allicininhibits the ability of endometrial cancer DDP-resistant strain Ishikawa/DDP to proliferate,invade and migrate while promoting apoptosis in tumor cells,and may reverse DDP resistance in Ishikawa/DDP cells by downregulating MDR1as well as P-gp expression.